Literature DB >> 27131006

Prevalence of Neisseria meningitidis carriage: a small-scale survey in Istanbul, Turkey.

Eda Kepenekli Kadayifci1, Deniz Güneşer Merdan, Ahmet Soysal, Ayşe Karaaslan, Serkan Atıcı, Rıza Durmaz, Perran Boran, İhsan Turan, Güner Söyletir, Mustafa Bakır.   

Abstract

INTRODUCTION: The human nasopharynx is the main reservoir of Neisseria meningitidis, and asymptomatic carriage is common. N. meningitidis one of the common causes of bacterial meningitis in Turkey, especially after the implementation of the national immunization program that includes conjugated pneumococcal and Haemophilus influenzae type b vaccines. The purpose of this study was to evaluate the prevalence of meningococcal carriage and determine the leading serogroup, which may help authorities to adapt appropriate meningococal vaccine into the national immunization programme.
METHODOLOGY: The prevalence of oropharyngeal carriage of N. meningitidis in 1,000 healthy subjects, 0-79 years of age, was investigated. Oropharyngeal swabs were collected during an 18-month period. Samples obtained were inoculated onto Thayer-Martin agar. The API-NH test and VITEK-MS system were used for identification of colonies. Multiplex real-time polymerase chain reaction assay was used to determine serogroups with serogroup-specific genes.
RESULTS: N. meningitidis was isolated from 6 of 1,000 subjects (0.6%). Meningoccocal carriers were between 21 and 40 years of age. All isolates were serogrouped as B, except one that did not survive on subculture. N. lactamica was isolated from 13 of 1,000 subjects (1.3%).
CONCLUSIONS: Carriage rate of meningococci in our study was relatively low. However, we detected that serogroup B was the leading strain in meningococcal carriage in Istanbul; choosing an appropriate meningococcal vaccine containing serogroup B should therefore be considered. High absolute humidity throughout the year in Istanbul may explain the low prevalence of carriage in our study. This should be verified with a multicenter national survey.

Entities:  

Mesh:

Year:  2016        PMID: 27131006     DOI: 10.3855/jidc.7483

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  6 in total

1.  The impact of meningococcal conjugate vaccine (MenACWY-TT) on meningococcal carriage in Hajj Pilgrims returning to Turkey.

Authors:  Hasan Tezer; Belgin Gülhan; Ayşe Simge Gişi; Selin Nar Ötgün; Saliha Kanık-Yüksek; Aslınur Özkaya-Parlakay; Selçuk Kılıç; Nuriye Ünal Şahin; Asiye Çiğdem Şimşek; Ateş Kara
Journal:  Hum Vaccin Immunother       Date:  2019-12-12       Impact factor: 3.452

2.  Longitudinal study of meningococcal carriage rates in university entrants living in a dormitory in South Korea.

Authors:  Heun Choi; Hyuk Min Lee; Woonji Lee; Jun Hyoung Kim; Hye Seong; Jung Ho Kim; Jin Young Ahn; Su Jin Jeong; Nam Su Ku; Joon-Sup Yeom; Kyungwon Lee; Hee Soo Kim; Philipp Oster; Jun Yong Choi
Journal:  PLoS One       Date:  2021-01-28       Impact factor: 3.240

Review 3.  The Burden of Invasive Vaccine-Preventable Diseases in Adults in the Middle East and North Africa (MENA) Region.

Authors:  Abdul Rahman Bizri; Abdulhakeem Althaqafi; Nawal Kaabi; Nathir Obeidat; Nadine Al Akoury; Hammam Haridy
Journal:  Infect Dis Ther       Date:  2021-03-22

Review 4.  Meningococcal Disease and Immunization Activities in Hajj and Umrah Pilgrimage: a review.

Authors:  Selim Badur; Mansour Khalaf; Serdar Öztürk; Rajaa Al-Raddadi; Ashraf Amir; Fayssal Farahat; Atef Shibl
Journal:  Infect Dis Ther       Date:  2022-05-19

5.  Meningococcal Carriage among Household Contacts of Patients with Invasive Meningococcal Disease in Kathmandu, Nepal: A Longitudinal Study.

Authors:  Supriya Sharma; Jyoti Acharya; Dominique A Caugant; Shreedhar Aryal; Megha Raj Banjara; Prakash Ghimire; Anjana Singh
Journal:  Pathogens       Date:  2021-06-22

6.  Asymptomatic carriers of Neisseria meningitidis and Moraxella catarrhalis in healthy children.

Authors:  A Maleki; Z Mirnaseri; E Kouhsari; M Taherikalani; I Pakzad; J Mohammadi; N Sadeghifard
Journal:  New Microbes New Infect       Date:  2020-05-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.